Security key
59564R708
BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW (BDRX)
CUSIP: 59564R708
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / SPON ADS NEW
- Total 13F shares
- 19,289
- Total 13F value
- $31,248
- Share change
- -44,390
- SEC-reported price per share
- $1.62
- Number of holders
- 5
- Value change
- -$131,225
- Number of buys
- 2
- Number of sells
- 2
Report period
Q1 2024
Institutions
5
Top holders
5
BDRX full security history
Ownership snapshot
Full 13F holder table
Biodexa Pharmaceuticals Plc SEC filings
Biodexa Pharmaceuticals Plc company facts
Broader feeds
Ownership snapshot
Top reported holders of BDRX - BIODEXA PHARMACEUTICALS PLC - SPON ADS NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BOOTHBAY FUND MANAGEMENT,...
Disclosed value leader
BOOTHBAY FUND MANAGEMENT,...
Comparable rows
0/7
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $119,509
7 rows are not safely comparable across share classes.
Showing 1-6 of 7 holder rows.
Quick read
BOOTHBAY FUND MANAGEMENT, LLC has the largest disclosed position value at $119.5K.
0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BOOTHBAY FUND MANAGEMENT, LLC's linked filing trail.
Disclosed position value
Top 5
BOOTHBAY FUND MANAGEMENT, LLC
$119.5K
RENAISSANCE TECHNOLOGIES LLC
$31K
BANK OF AMERICA CORP /DE/
$14K
GAMMA Investing LLC
$1.7K
UBS Group AG
$1.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$119,509
44,593 shares
|
— | 31 Dec 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$31,000
11,700 shares
|
— | 31 Dec 2023 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$14,032
5,236 shares
|
— | 31 Dec 2023 |
| GAMMA Investing LLC |
13F
Company
|
—
denominator unverified
|
$1,668
1,036 shares
|
— | 31 Dec 2023 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$1,608
600 shares
|
— | 31 Dec 2023 |
| RHUMBLINE ADVISERS |
13F
Company
|
—
denominator unverified
|
$1,332
498 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
19,289
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
5
Q1 2024 holders
5
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|